NMTRQ (9 Meters Biopharma) Research & Development: $32.44 Mil (TTM As of Mar. 2023)


What is 9 Meters Biopharma Research & Development?

9 Meters Biopharma NMTRQ -90.00% Research & Development is $32.44 Mil as of Mar. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. 9 Meters Biopharma's Research & Development for the three months ended in Mar. 2023 was $9.80 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was $32.44 Mil.

9 Meters Biopharma  (OTCPK:NMTRQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

9 Meters Biopharma Research & Development Related Terms

9 Meters Biopharma Research & Development Historical Data

* Premium members only.

The historical data trend for 9 Meters Biopharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

9 Meters Biopharma Research & Development Chart

9 Meters Biopharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.56 13.72 10.93 22.00 31.01

9 Meters Biopharma Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.37 7.55 6.30 8.80 9.80

9 Meters Biopharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $32.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $32.44 Mil mean?
9 Meters Biopharma (NMTRQ) has a Research & Development of $32.44 Mil as of Mar. 2023. Research and development expense is the total cost for research and development activities. View historical data on 9 Meters Biopharma and its competitors.
Is 9 Meters Biopharma's Research & Development too high?
9 Meters Biopharma's current Research & Development is $32.44 Mil.
How does 9 Meters Biopharma's Research & Development compare to USRM and NOVNQ?
9 Meters Biopharma's Research & Development of $32.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on 9 Meters Biopharma and its competitors. 9 Meters Biopharma's current Research & Development is $32.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 9 Meters Biopharma stock overvalued right now?
9 Meters Biopharma (NMTRQ) has a current Research & Development of $32.44 Mil. The current Research & Development is $32.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For 9 Meters Biopharma (NMTRQ), the current Research & Development is $32.44 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

9 Meters Biopharma Business Description

Address 4509 Creedmoor Road, Suite 600, Raleigh, NC, USA, 27612
9 Meters Biopharma Inc is a clinical-stage company pioneering novel treatments for people with rare digestive diseases, gastrointestinal (GI) conditions with unmet needs, and debilitating disorders in which the biology of the gut is a contributing factor. Its pipeline includes vurolenatide, a proprietary Phase 3 long-acting glucagon-like-peptide 1 (GLP-1) agonist for short bowel syndrome (SBS) and a robust pipeline of early-stage candidates for undisclosed rare diseases and/or unmet needs.